AI in Medical Imaging

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".

Deadline for manuscript submissions: closed (18 February 2022) | Viewed by 518

Special Issue Editor


E-Mail Website
Guest Editor
1. Department of Medical Physiology and Biophysics, Faculty of Medicine, University of Seville, 41004 Sevilla, Spain
2. National Accelerators' Center, University of Seville, 41004 Sevilla, Spain
Interests: molecular imaging; positron emission tomography–PET; computed tomography–CT; medical imaging; PET detectors; boron neutron capture therapy–BNCT; artificial intelligence applied to medical imaging
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Artificial Intelligence and especially Machine Learning are playing an increasing role in Medical Imaging. On one hand, AI presents solutions which are of (in)sufficient accuracy or are difficult to implement in a clinical workflow. On the other hand, MD wants to have insight into how the classification or suggested diagnosis or outcome was calculated instead of just seeing an expensive AI black box. AI needs a common discussion platform where all key opinion leaders can express their concerns and results in an organized way.

In this topic, we invite AI/ML developers, computer scientists, academics, MDs (radiologists, neurologists, critical care doctors, etc.), and hospital managers to present their results of implementation of AI into medical imaging of any modality, the effectiveness of this process, and the gains and losses in terms of patient outcome and (monetary) investments. We welcome original articles, case reports, and reviews.  

Prof. Dr. Marcin Balcerzyk
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop